<?xml version="1.0" encoding="UTF-8"?>
<p>Several other outcomes were of clinical interest. New-onset diabetes after transplantation occurred in 10 (17%) recipients. Cardiovascular events occurred in 3 (5%) patients. Seven (12%) had cytomegalovirus infection, and four (7%) patients developed neoplasia during the follow-up period, none of which was hepatocellular carcinoma (
 <xref ref-type="table" rid="T4">Table 4</xref>).
</p>
